Fluid therapy to restore and/or maintain tissue perfusion may affect patient outcomes in perioperative, emergency, and intensive care. Kinetic analyses and outcome-oriented studies have provided more insight into fluid management. Crystalloids are slowly distributed to the interstitial space, and the efficiency (proportion of infused fluid retained in the bloodstream) is 50%−75% as long as infusion continues and may increase up to 100% when the arterial pressure has decreased. Elimination of the infused fluid during general anesthesia and surgery is very slow, amounting to only 10%–20% compared with that in conscious patients. When the endothelial glycocalyx layer is degraded in sepsis or trauma-induced systemic inflammation, turnover of colloids and crystalloids is accelerated and the efficiency is reduced, which may lead to tissue edema, inflammation, poor wound healing, and organ dysfunction. Balanced crystalloids are pragmatic initial resuscitation fluids and improve patient outcomes compared to saline (0.9% sodium chloride). Albumin may be beneficial, but other synthetic colloids appear to increase the risk of acute kidney injury and death among patients in the intensive care unit. Fluid kinetics is likely to change based on patient physiological conditions (e.g., general anesthesia, surgery, stress, dehydration, blood pressure, or inflammation) and fluid types. To maximize efficacy and minimize iatrogenic side effects, fluids should be prescribed based on individual patient factors, disease states, and other treatment remedies.
Citations
Citations to this article as recorded by
Pulse pressure variation guided goal-direct fluid therapy decreases postoperative complications in elderly patients undergoing laparoscopic radical resection of colorectal cancer: a randomized controlled trial Qiu-Rong Wu, Zi-Zuo Zhao, Ke-Ming Fan, Hui-Ting Cheng, Bin Wang International Journal of Colorectal Disease.2024;[Epub] CrossRef
Prevalence and associated factors of postoperative orthostatic intolerance at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia, 2022: cross sectional study Negesse Zurbachew Gobezie, Nigussie Simeneh Endalew, Hailu Yimer Tawuye, Habtu Adane Aytolign BMC Surgery.2023;[Epub] CrossRef
Remimazolam and serious adverse events Sander Kempenaers, Tom G. Hansen, Marc Van de Velde European Journal of Anaesthesiology.2023; 40(11): 841. CrossRef
The incidence and risk factors of proximal lower extremity deep vein thrombosis without pharmacologic prophylaxis in critically ill surgical Taiwanese patients: A prospective study Ting-Lung Lin, Wen-Hao Liu, Wei-Hung Lai, Ying-Ju Chen, Po-Hsun Chang, I-Ling Chen, Wei-Feng Li, Yueh-Wei Liu, Eric J Ley, Chih-Chi Wang Journal of the Intensive Care Society.2023;[Epub] CrossRef
Meropenem pharmacokinetics in critically ill patients with or without burn treated with or without continuous veno‐venous haemofiltration Daniel J. Selig, Kevin S. Akers, Kevin K. Chung, Kaitlin A. Pruskowski, Jeffrey R. Livezey, Elaine D. Por British Journal of Clinical Pharmacology.2022; 88(5): 2156. CrossRef
Does perioperative fluid management affect the development of postoperative complications in major gastrointestinal tract surgery? A retrospective cohort study Mehmet Mustafa ALTINTAŞ, Kemal Tolga SARAÇOĞLU, Aytaç Emre KOCAOĞLU, Fırat MÜLKÜT, Ayten SARACOĞLU, Selçuk KAYA, Ayhan ÇEVİK Journal of Surgery and Medicine.2022; 6(2): 90. CrossRef
A Porcine Sepsis Model With Numerical Scoring for Early Prediction of Severity Attila Rutai, Bettina Zsikai, Szabolcs Péter Tallósy, Dániel Érces, Lajos Bizánc, László Juhász, Marietta Zita Poles, József Sóki, Zain Baaity, Roland Fejes, Gabriella Varga, Imre Földesi, Katalin Burián, Andrea Szabó, Mihály Boros, József Kaszaki Frontiers in Medicine.2022;[Epub] CrossRef
Risk Factors for and Outcomes Associated With Peri-Intubation Hypoxemia: A Multicenter Prospective Cohort Study Nathan J. Smischney, Ashish K. Khanna, Ernesto Brauer, Lee E. Morrow, Uchenna R. Ofoma, David A. Kaufman, Ayan Sen, Chakradhar Venkata, Peter Morris, Vikas Bansal Journal of Intensive Care Medicine.2021; 36(12): 1466. CrossRef
Inflammatory response, fluid balance and outcome in emergency high‐risk abdominal surgery Mirjana Cihoric, Henrik Kehlet, Morten L. Lauritsen, Jakob Højlund, Katrine Kanstrup, Nicolai B. Foss Acta Anaesthesiologica Scandinavica.2021; 65(6): 730. CrossRef
A review on the physiological and pathophysiological role of endothelial glycocalyx Huan‐qiu Liu, Ji Li, Cheng‐luan Xuan, Hai‐chun Ma Journal of Biochemical and Molecular Toxicology.2020;[Epub] CrossRef
Science‐in‐brief: The role of the glycocalyx in critically ill patients with reference to the horse Bettina Dunkel Equine Veterinary Journal.2020; 52(6): 790. CrossRef
Urinary examination has formed part of patient assessment since the earliest days of medicine. Current definitions of oliguria are essentially arbitrary, but duration and intensity of oliguria have been associated with an increased risk of mortality, and this risk is not completely attributable to the development of concomitant acute kidney injury (AKI) as defined by changes in serum creatinine concentration. The increased risk of death associated with the development of AKI itself may be modified by directly or indirectly by progressive fluid accumulation, due to reduced elimination and increased fluid administration. None of the currently extant major illness severity scoring systems or outcome prediction models use modern definitions of AKI or oliguria, or any values representative of fluid volumes variables. Even if a direct relationship with mortality is not observed, then it is possible that fluid balance or fluid volume variables mediate the relationship between illness severity and mortality in the renal and respiratory physiological domains. Fluid administration and fluid balance may then be an important, easily modifiable therapeutic target for future investigation. These relationships require exploration in large datasets before being prospectively validated in groups of critically ill patients from differing jurisdictions to improve prognostication and mortality prediction.
Citations
Citations to this article as recorded by
Management of oliguria Marlies Ostermann, Andrew D. Shaw, Michael Joannidis Intensive Care Medicine.2023; 49(1): 103. CrossRef
Nomenclature and diagnostic criteria for acute kidney injury – 2020 consensus of the Taiwan AKI-task force Shao-Yu Yang, Terry Ting-Yu Chiou, Chih-Chung Shiao, Hugo You-Hsien Lin, Ming-Jen Chan, Che-Hsiung Wu, Chiao-Yin Sun, Wei-Jie Wang, Yen-Ta Huang, Vin-Cent Wu, Yung-Chang Chen, Ji-Tsung Fang, Shang-Jyh Hwang, Heng-Chih Pan Journal of the Formosan Medical Association.2022; 121(4): 749. CrossRef
Haemodynamic frailty – A risk factor for acute kidney injury in the elderly Neil G. Docherty, Christian Delles, Patrick D’Haese, Anita T. Layton, Carlos Martínez-Salgado, Benjamin A. Vervaet, Francisco J. López-Hernández Ageing Research Reviews.2021; 70: 101408. CrossRef
Does Fluid Type and Amount Affect Kidney Function in Critical Illness? Neil J. Glassford, Rinaldo Bellomo Critical Care Clinics.2018; 34(2): 279. CrossRef
Despite near ubiquity, information regarding fluids consumption at a health care systems level, and patient exposure at an individual level, is surprisingly limited in the medical literature. The epidemiology of the foundational medical intervention of intravenous fluid administration is incredibly complex, with millions of patients being exposed internationally every year. Fluid is being given for different reasons, to different targets, following different triggers, by different specialties in different countries, and any observations that can be made are thought to have limited external validity to other jurisdictions and patient groups. The independent effects of fluid administration and fluid accumulation are very hard to separate from other markers of illness severity and aspects of the process of care. Fluid accumulation can result in organ injury, even when the fluid is being given to purportedly ameliorate or prevent such injury, and if it were independently associated with mortality then would be an easily accessible and modifiable risk factor for subsequent morbidity or death. Despite their ubiquity, it is clear that we have limited understanding of the effects of the intravenous fluids we use daily in the most vulnerable of patient groups. The research agenda in this field is large and urgent.
Citations
Citations to this article as recorded by
Closed-Loop Control of Fluid Resuscitation Using Reinforcement Learning Elham Estiri, Hossein Mirinejad IEEE Access.2023; 11: 140569. CrossRef
Fluid Stewardship of Maintenance Intravenous Fluids John R. Carr, W. Anthony Hawkins, Andrea Sikora Newsome, Susan E. Smith, Clemmons Amber B, Christopher M. Bland, Trisha N. Branan Journal of Pharmacy Practice.2022; 35(5): 769. CrossRef
Clinician attitudes and concordance with self-assessed and actual intravenous fluid prescribing patterns: A single-institution evaluation of survey and electronic prescribing data Michelle C. Spiegel, Annie N. Simpson, Nandita R. Nadig, Dee W. Ford, Andrew J. Goodwin The American Journal of the Medical Sciences.2022; 364(1): 36. CrossRef
Acetate‐ versus lactate‐buffered crystalloid solutions: A systematic review with meta‐analysis and trial sequential analysis Karen Louise Ellekjaer, Anders Perner, Praleene Sivapalan, Morten Hylander Møller Acta Anaesthesiologica Scandinavica.2022; 66(7): 782. CrossRef
A fuzzy model for predicting burn patients’ intravenous fluid resuscitation rate Sayma Alam Suha, M. Akhtaruzzaman, Tahsina Farah Sanam Healthcare Analytics.2022; 2: 100070. CrossRef
Development and implementation of a clinical decision support-based initiative to drive intravenous fluid prescribing Michelle C. Spiegel, Annie N. Simpson, Achsah Philip, Carolyn M. Bell, Nandita R. Nadig, Dee W. Ford, Andrew J. Goodwin International Journal of Medical Informatics.2021; 156: 104619. CrossRef
Influence of acetate containing fluid versus lactate containing fluid on acid-base status, electrolyte level, and blood lactate level in dehydrated dogs Annika Heitland, Ute Klein-Richers, Katrin Hartmann, René Dörfelt Veterinary World.2021; : 2714. CrossRef
Infusion fluids: a clinical pharmacologist’s view E.A. Ushkalova, S.K. Zyryanov, K.E. Zatolochina, O.I. Butranova Anesteziologiya i reanimatologiya.2021; (6): 100. CrossRef
Pathophysiology of Volume Administration in Septic Shock and the Role of the Clinical Pharmacist Brittany D. Bissell, Breanne Mefford Annals of Pharmacotherapy.2020; 54(4): 388. CrossRef
Lactate versus acetate buffered intravenous crystalloid solutions: a scoping review Karen L. Ellekjaer, Anders Perner, Martine M. Jensen, Morten H. Møller British Journal of Anaesthesia.2020; 125(5): 693. CrossRef
Balanced Crystalloid Solutions Matthew W. Semler, John A. Kellum American Journal of Respiratory and Critical Care Medicine.2019; 199(8): 952. CrossRef
Does Fluid Type and Amount Affect Kidney Function in Critical Illness? Neil J. Glassford, Rinaldo Bellomo Critical Care Clinics.2018; 34(2): 279. CrossRef
Resuscitation fluids Jonathan D. Casey, Ryan M. Brown, Matthew W. Semler Current Opinion in Critical Care.2018; 24(6): 512. CrossRef
Utility of Volume Assessment Using Bioelectrical Impedance Analysis in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective Observational Study Ki Hyun Park, Jung-ho Shin, Jin Ho Hwang, Su Hyun Kim The Korean Journal of Critical Care Medicine.2017; 32(3): 256. CrossRef